Skip to content

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2023

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2023

The information is for S. enterica culture isolates received during the designated year.

Serotypic name No. tested Sterile site specimens Non-sterile site specimens
Total Not susceptible % Total Not susceptible %
Ciprofloxacin Ceftriaxone Ciprofloxacin Ceftriaxone
Enteritidis 505 117 56.4% 8.5% 388 46.1% 11.3%
I 4:i:- 424 9 44.4% 22.2% 415 47.7% 15.2%
Typhimurium 108 2 100.0% 0.0% 106 81.1% 5.7%
Rissen 131 6 66.7% 0.0% 125 33.6% 4.0%
London 72 3 100.0% 0.0% 69 79.7% 4.3%
Derby 59 2 0.0% 0.0% 57 31.6% 1.8%
Saintpaul 10 0 - - 10 70.0% 20.0%
Goldcoast 23 1 0.0% 0.0% 22 36.4% 0.0%
Typhi 13 12 75.0% 0.0% 1 100.0% 0.0%
Braenderup 12 0 - - 12 41.7% 0.0%
Wandsworth 1 0 - - 1 0.0% 0.0%
Stanley 87 5 0.0% 0.0% 82 8.5% 3.7%
Bareilly 13 1 0.0% 0.0% 12 33.3% 8.3%
Meleagridis 11 0 - - 11 36.4% 0.0%
Weltevreden 21 1 0.0% 0.0% 20 15.0% 0.0%
I 19:g,s,t 0 0 - - 0 - -
Give 6 1 100.0% 0.0% 5 60.0% 0.0%
Singapore 2 0 - - 2 50.0% 0.0%
Reading 0 0 - - 0 - -
Kentucky 21 2 100.0% 100.0% 19 100.0% 73.7%
Others 221 19 15.8% 10.5% 202 38.6% 13.9%


Remarks:

Multiple strains may have been received from the same patient.